UR

Ulhas Rajaram Puranik

Active Director Director DIN 01350847
DIN 01350847 First appointment Mar 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 8 active board seats
Past companies 6 historical roles
Total affiliations 14 Since Mar 2007
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 15 Mar 2007
Active appointments 8
Total timeline records 14

Ulhas Rajaram Puranik (DIN 01350847) has 14 recorded board appointments in Indian companies, the first from March 2007, of which 8 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2007
Spiral Medtech Private Limited Director · 2025 – present
Current
Sava Healthcare Limited Additional Director · 2024 – present
Current
Avet Lifesciences Private Limited Director · 2021 – present
Current
Optimus Medtech Private Limited Director · 2014 – present
Current
Cure Laboratories Private Limited Director · 2009 – present
Current
D P Consultancy Services Private Limited Director · 2008 – present
Current
Cure Exports Private Limited Director · 2007 – present
Current
Cure Medicines (India) Private Limited Director · 2007 – present
Current
Dynamic Remedies Pvt Ltd Director · 2012 – 2013
Previous
Uv Ayurgen Pharma Private Limited Director · 2011 – 2013
Previous
Safetec Laboratories Private Limited Director · 2011 – 2011
Previous
Cosmic Research Private Limited Director · 2011 – 2021
Previous
Maharashtra Ayurved Center Private Limited Additional Director · 2008 – 2009
Previous
Green Pharmacy Private Limited Director · 2008 – 2011
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available